论文部分内容阅读
日本三得利生物医学研究所开发抗癌效果好的植物生物碱的新型衍生物(SUN4599)成功。预定在10月21～23日在札幌市召开的日本癌学会上发表。在动物实验中,此化合物的效果比目前广泛应用的抗癌剂阿霉素高几倍,而且几乎没有心脏毒性等副作
Japan Suntory Institute of Biomedicine developed a new anti-cancer plant alkaloid derivatives (SUN4599) success. It is scheduled to be presented at the Japan Cancer Society in Sapporo from October 21 to 23. In animal experiments, the compound is several times more potent than the most widely used anticancer drug doxorubicin and has few side effects such as cardiotoxicity